Produkty 20972-29-6

CAS 20972-29-6 występuje w naszej ofercie pod nazwami: Galβ(1–3)GalNAc, Galacto-N-biose, Galacto-N-biose, min. 90 %, 2 mg, Galacto-N-biose, min. 90 %, 5 mg, Galacto-N-biose, min. 90 %, 10 mg. Oferty producentów: GLPBio, TCI, Biosynth, Roth, Chemat. Dostępne opakowania: 1mg, -, 5mg, 2mg, 10mg, 25mg, 50mg.

Galβ(1–3)GalNAc
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 1116,58
Zobacz produkt
Galacto-N-biose
TCI, Biosynth
  • opakowanie: -, 5mg, 2mg, 10mg
  • Warianty: 6
od 110,00
Zobacz produkt
Galacto-N-biose, min. 90 %, 2 mg
Roth
  • opakowanie: 2mg
  • Warianty: 1
od 2477,80
Zobacz produkt
Galacto-N-biose, min. 90 %, 5 mg
Roth
  • opakowanie: 5mg
  • Warianty: 1
od 4762,08
Zobacz produkt
Galacto-N-biose, min. 90 %, 10 mg
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 9056,92
Zobacz produkt
Galacto-N-biose, min. 90 %, 25 mg
Roth
  • opakowanie: 25mg
  • Warianty: 1
od 19156,86
Zobacz produkt
2-Acetamido-2-deoxy-3-O-(-D-galactopyranosyl)-D-galactopyranose
Chemat
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 717,20
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

N-[(3R,4R,5R,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide (CAS 20972-29-6) to związek chemiczny o wzorze sumarycznym C14H25NO11 i masie molowej 383.35 g/mol. Nazwa systematyczna IUPAC: N-[(3R,4R,5R,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide. InChIKey: HMQPEDMEOBLSQB-UITYFYQISA-N.

Dane identyfikacyjne
Wzór sumarycznyC14H25NO11
Masa molowa383.35 g/mol
Nazwa IUPACN-[(3R,4R,5R,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
InChIKeyHMQPEDMEOBLSQB-UITYFYQISA-N
SMILESCC(=O)N[C@@H]1[C@H]([C@H]([C@H](OC1O)CO)O)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: GlyTouCan:G78436BB, 2-(acetylamino)-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactopyranose, Galacto-N-biose, beta-D-Galp-(1->3)-D-GalpNAc, T Antigen, TF epitope, Thomsen-Friedenreich epitope, 2-Acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactopyranose, beta-D-Galactosyl-(1->3)-N-acetyl-D-galactosamine, (Gal)1 (GalNAc)1
Powiązane formy tego związku
N-[(3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C14H25NO11
N-[(3R,4R,5R,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C14H25NO11
Izomery (ten sam wzór sumaryczny)
N-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide C14H25NO11
N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2S,3S,4R,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]oxyoxan-3-yl]acetamide C14H25NO11
N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-3-yl]acetamide C14H25NO11
N-[(3R,4R,5R,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C14H25NO11
N-[(2R,3R,4S,5R)-4,5,6-trihydroxy-1-oxo-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide C14H25NO11
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]acetamide C14H25NO11
N-[(2R,3R,4R,5R)-4,5,6-trihydroxy-1-oxo-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide C14H25NO11
N-[(2S,3S,4R,5S)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4S,5R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]acetamide C14H25NO11
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3R,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]acetamide C14H25NO11
N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C14H25NO11